Records containing: Peanut Allergy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ENP-501 in Non-Peanut Allergic Participants and Participants With a Known Peanut Allergy
-
CLINICAL_TRIALS study record update · 2026-04-09A First-in-Human, Ascending Dose, Open-label, Multicenter Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of UKK-0018 in Peanut Allergic Individuals
-
CLINICAL_TRIALS study record update · 2026-04-09Outcomes of Clinical Food Oral Immunotherapy for Peanut Allergy
-
CLINICAL_TRIALS study record update · 2026-03-24A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Safety of Epicutaneous Immunotherapy With DBV712 250 mcg in 1-through 3-year-old Children With Peanut Allergy
-
CLINICAL_TRIALS study record update · 2026-03-18A Phase I/II Trial in 3 Parts Assessing the Safety, Tolerability, and Efficacy of a Once-daily Peanut Sublingual Immunotherapy (SLIT) Tablet in Adults, Adolescents, and Children With Peanut Allergy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-13A Phase I Clinical Trial to Evaluate the Safety and Tolerability of VLP Peanut in Healthy Subjects and Subjects With Peanut Allergy and to Explore Preliminary Signals of Its Efficacy (PROTECT)
-
CLINICAL_TRIALS study record update · 2026-03-09Fiber Supplementation In Children With Peanut Allergy On Oral Immunotherapy: A Randomized Controlled Pilot Study
-
CLINICAL_TRIALS study record update · 2026-03-03Oral Immunotherapy Comparing Standard and Autoclaved Peanuts in Peanut-Allergic Individuals
-
CLINICAL_TRIALS study record update · 2026-02-09Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety
-
CLINICAL_TRIALS study record update · 2026-01-15Viaskin® Peanut (DBV712) Compassionate Use in Peanut-allergic Children Previously Enrolled in a DBV712 Clinical Study
-
CLINICAL_TRIALS study record update · 2025-12-08High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety
-
CLINICAL_TRIALS study record update · 2025-11-14A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study With Single Blind Sentinel Period to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IGNX001 in Peanut-Allergic Participants
-
CLINICAL_TRIALS study record update · 2025-10-30Efficacy of Tezepelumab in Peanut Oral Immunotherapy: a Double-Blind, Randomized, Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-10-15A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
-
CLINICAL_TRIALS study record update · 2025-08-24A Phase II Trial to Evaluate the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
-
CLINICAL_TRIALS study record update · 2025-06-29Using Commonly Available Food Products To Treat Food Allergy (NATASHA Study)
-
CLINICAL_TRIALS study record update · 2025-06-06EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children
-
CLINICAL_TRIALS study record update · 2025-06-04Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT (SmaChO)
-
CLINICAL_TRIALS study record update · 2025-05-21Phase 2 Randomized Controlled Trial Using Biologics to Improve Multi OIT Outcomes
-
CLINICAL_TRIALS study record update · 2025-05-01Effect of an Immune-supportive Diet on Gut Permeability and Allergic Symptoms in Children With Peanut and/or Nut Allergy
-
CLINICAL_TRIALS study record update · 2025-04-30A Multicenter Double-blind, Randomized, Placebocontrolled Phase I/II Study to Determine the Safety, Tolerability, Potential Efficacy and Dose Finding of INP20, an Oral Formulation for Treatment of Immunotherapy in Peanut-allergic Patients
-
CLINICAL_TRIALS study record update · 2025-02-07Challenging to Food With Escalating Thresholds for Reducing Food Allergy
-
CLINICAL_TRIALS study record update · 2025-02-06Peanut/Tree Nut Desensitization and Induction of Tolerance in Children
-
CLINICAL_TRIALS study record update · 2024-12-19A Multicenter, Open-Label, Longer-Term Study of AR101 Characterized Oral Desensitization Immunotherapy in Subjects Who Participated in a Prior AR101 Study
-
CLINICAL_TRIALS study record update · 2024-12-16A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age.